Literature DB >> 19861492

Stat3 promotes directional cell migration by regulating Rac1 activity via its activator betaPIX.

Terk Shin Teng1, Baohong Lin, Ed Manser, Dominic Chi Hiung Ng, Xinmin Cao.   

Abstract

Stat3 is a member of the signal transducer and activator of transcription family, which is important for cytokine signaling as well as for a number of cellular processes including cell proliferation, anti-apoptosis and immune responses. In recent years, evidence has emerged suggesting that Stat3 also participates in cell invasion and motility. However, how Stat3 regulates these processes remains poorly understood. Here, we find that loss of Stat3 expression in mouse embryonic fibroblasts leads to an elevation of Rac1 activity, which promotes a random mode of migration by reducing directional persistence and formation of actin stress fibers. Through rescue experiments, we demonstrate that Stat3 can regulate the activation of Rac1 to mediate persistent directional migration and that this function is not dependent on Stat3 transcriptional activity. We find that Stat3 binds to betaPIX, a Rac1 activator, and that this interaction could represent a mechanism by which cytoplasmic Stat3 regulates Rac1 activity to modulate the organization of actin cytoskeleton and directional migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861492     DOI: 10.1242/jcs.057109

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  40 in total

1.  Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42.

Authors:  Gina L Razidlo; Kevin M Burton; Mark A McNiven
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

2.  Knockout of the neonatal Fc receptor in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

Authors:  Pantipa Tonsawan; James Dylewski; Linda Lewis; Judith Blaine
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

3.  STAT3-regulated RhoA drives reactive astrocyte dynamics.

Authors:  Francois Renault-Mihara; Hideyuki Okano
Journal:  Cell Cycle       Date:  2017-09-29       Impact factor: 4.534

4.  Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.

Authors:  Joseph Chen; Badriprasad Ananthanarayanan; Kelsey S Springer; Kayla J Wolf; Sharon M Sheyman; Vivien D Tran; Sanjay Kumar
Journal:  Cancer Res       Date:  2019-10-22       Impact factor: 12.701

5.  Upregulation of CCR3 by age-related stresses promotes choroidal endothelial cell migration via VEGF-dependent and -independent signaling.

Authors:  Haibo Wang; Erika S Wittchen; Yanchao Jiang; Balamurali Ambati; Hans E Grossniklaus; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

6.  Quantitative analysis of random migration of cells using time-lapse video microscopy.

Authors:  Prachi Jain; Rebecca A Worthylake; Suresh K Alahari
Journal:  J Vis Exp       Date:  2012-05-13       Impact factor: 1.355

7.  STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction.

Authors:  Hoainam Nguyen-Jackson; Athanasia D Panopoulos; Huiyuan Zhang; Haiyan S Li; Stephanie S Watowich
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

8.  IbeA and OmpA of Escherichia coli K1 exploit Rac1 activation for invasion of human brain microvascular endothelial cells.

Authors:  Ravi Maruvada; Kwang Sik Kim
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

9.  Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.

Authors:  S Kim; Y M Yoon; Y-S Han; J H Lee; J Hur; S H Lee
Journal:  Cell Prolif       Date:  2018-05-02       Impact factor: 6.831

10.  Role of STAT3 in in vitro transformation triggered by TRK oncogenes.

Authors:  Claudia Miranda; Tiziana Fumagalli; Maria Chiara Anania; Maria Grazia Vizioli; Sonia Pagliardini; Marco A Pierotti; Angela Greco
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.